Supplementary Figures and
. MAPK activation by different concentrations of M-CSF or RANKL. Osteoclast precursors were treated with M-CSF (0.5, 1, and 25 ng/ml) or RANKL (10, 100, and 500 ng/ml) for the indicated times, after which cell lysates were subjected to immunoblot analysis with antibodies to total or phosphorylated forms of ERK, p38, and JNK. Data are representative of three independent experiments. Figure S2 . MAPK activation by M-CSF or RANKL at different stages of osteoclast differentiation.
Pre-osteoclasts or mature osteoclasts were prepared by treatment of osteoclast precursors with M-CSF (30 ng/mL) and RANKL (100 ng/mL) for 2 or 4 days, respectively, after which the cells were deprived of both ligands for 6 hours before stimulation with M-CSF (25 ng/mL) or RANKL (500 ng/mL) for the indicated times. Cell lysates were then subjected to immunoblot analysis of MAPK activation. The gel images are representative of three independent experiments. Osteoclast precursors were treated with M-CSF (25 ng/ml) or RANKL (500 ng/ml) for the indicated times, after which cell lysates were subjected to immunoblot analysis with antibodies specific for total or phosphorylated forms of MKKs, including MEK1/2, MKK3/6, MKK4, and MKK7. The gel images are representative of three independent experiments. 
